Ger Brennan

31 results

Mairéad McCaul
Mairéad McCaul to lead MSD’s human health drug business in Ireland

MSD, the maker of cancer blockbuster Keytruda, has named a new head of its Irish business just as the company develops a major new plant in Swords. M(...)

If the clinical trial numbers are near what is replicated in the field, it will help to overcome some resistance to the vaccine. Photograph: John Cairns/University of Oxford/AFP via Getty Images
Vaccine take-up will determine success in Covid-19 battle

After a year when it regularly seemed as though things were destined only to get worse, we have had a run of remarkably positive news on the Covid-19 (...)

Martin McVicar of CombiLift: demand from many customers in the 80 countries where it sells forklifts is growing in some cases. Photograph: Peter Murtagh
Open for business: How industry has adapted to survive the lockdown

The triggering of Level 5 restrictions this week as the State battles to cope with Covid-19 has forced many businesses to shut their doors once more a(...)

More than 30,000 people are employed in the pharma sector in Ireland
Ireland is a world leader in producing cancer therapies but we lag behind on access

Ireland is a world leader in making and producing cancer therapies, so why do Irish patients have to wait so long to access innovative medicines? It(...)

Pharma giant MSD has agreed to buy Takeda’s state-of-the-art biologics plant in Dunboyne, Co Meath, where around 200 workers are currently employed
MSD buys Takeda biologics plant in Dunboyne

Pharma giant MSD has agreed to buy a state-of-the-art biologics plant in Dunboyne, Co Meath, where around 200 workers are currently employed. The dea(...)

At $3.3bn the cancer blockbuster drug Keytruda now accounts for more than a quarter of all the sales of MSD’s parent, which trades as Merck in the US and Canada. Photograph: Robbie Reynolds
MSD looking for 200 staff across four Irish sites

Pharma company MSD is looking to fill up to 200 roles across its four Irish sites between now and the end of the year. The sector has been one of the(...)

Position paper warns that the ‘current system of assessing new medicines in Ireland is not working’, with the country ranked bottom of 13 western European states in its speed of bringing new cancer medicines to patients
Cancer drug trials hit by lack of funding , report warns

Trials of new drugs for lymphoma, testicular cancer and endometrial cancer have been unable to open in Ireland because of a cut in funding for cancer (...)

Ger Brennan, who trained as a nurse, was keen to merge his medical interest with sales. After ‘a hundred PFOs’ applying to be a medical rep he landed a contract job with Bayer
‘We’re not even using the UK as a landbridge’

Brexit doesn’t worry Ger Brennan. It’s a startling take from an industry leader, given how much the relentless uncertainty over the manner of the even(...)

Artist’s impression of new MSD site at Swords, expanded to 43,000sq m from previous 31,000sq m plant.
Pharma giant seeks planning for Swords plant

MSD has submitted planning permission for the construction of its major new biotech plant in Swords. The company’s new biologics facility will be bu(...)

Ger Brennan, managing director for human health at MSD Ireland: “Surgical treatment is not changing but we have seen major changes in new innovative medicines.”
Cancer research developing new ways to tackle old enemies

Cancer is the second-biggest killer in Ireland, according to the Irish Cancer Society. It accounts for about 30 per cent of deaths every year; heart d(...)

  • 1
  • 2
  • 3
  • 4
  • Next ›
  • Last »